Blood Oxygenation Level-Dependent (BOLD) Contrast Magnetic Resonance Imaging (MRI) for Prediction of Pancreas Cancer Chemoradiotherapy Response

Blood Oxygenation Level-Dependent (BOLD) Contrast Magnetic Resonance Imaging (MRI) for Prediction of Pancreas Cancer Chemoradiotherapy Response - BOLD Contrast MRI for Prediction of Pancreas Cancer Chemoradiotherapy Response

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020466

Enrollment

Registered

2016-01-11

Start date

2016-01-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreas Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Histological confirmation of pancreas cancer 2) Scheduled to undergo chemoradiation for locally advanced pancreas cancer (T3-4, N0-1, M0 according to the International Union Against Cancer TNM system) 3) Written informed consent is obtained.

Exclusion criteria

Exclusion criteria: 1-2) Contraindication to MRI (eg, noncompatible biometallic implants or claustrophobia) 3) During pregnancy 4) Chronic obstructive pulmonary disease 5) Heart failure 6) Less than 20 years of age

Design outcomes

Primary

Measure	Time frame
Relationship between BOLD response and tumor regression after chemoradiation	—

Secondary

Measure	Time frame
Relationship between BOLD response and patient prognosis after chemoradiation	—

Countries

Japan

Contacts

Public ContactYoshihiko Fukukura

Kagoshima University Hospital Radiology

fukukura@m.kufm.kagoshima-u.ac.jp099-275-5417

Outcome results